Iopromide for Contrast-Enhanced Mammography: A Systemic Review and Meta-Analysis of Pertinent Literature.

Endrikat, Jan; Khater, Hassan; Boreham, Alexander Dp; Fritze, Sabine; Schwenke, Carsten; Bhatti, Aasia; Trnkova, Zuzana Jirakova; Seidensticker, Peter

Endrikat, Jan; Khater, Hassan; Boreham, Alexander Dp; Fritze, Sabine; Schwenke, Carsten; Bhatti, Aasia; Trnkova, Zuzana Jirakova; Seidensticker, Peter.

Afiliação

Endrikat J; Radiology R&D, Bayer AG, Berlin, Germany.
Khater H; Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, Homburg, Germany.
Boreham AD; Radiology R&D, Bayer AG, Berlin, Germany.
Fritze S; Co.medical, Berlin, Germany.
Schwenke C; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Product Information, Bayer AG, Berlin, Germany.
Bhatti A; SCO: SSiS, Minden, Germany.
Trnkova ZJ; Benefit Risk Management Pharmacovigilance, Bayer US LLC, Whippany, NJ, USA.
Seidensticker P; Radiology R&D, Bayer AG, Berlin, Germany.

Breast Cancer (Auckl) ; 17: 11782234231189467, 2023.

Article em En | MEDLINE | ID: mdl-37600467

Palavras-chave

Iopromide; contrast-enhanced mammography

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: Breast Cancer (Auckl) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google